VECTIVBIO HOLDING - Stock (VECT)

CUSIP: H9060V101

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Stock
Total 13F shares
23,339,231
Share change
+65,307
Total reported value
$109,868,000
Price per share
$4.71
Number of holders
16
Value change
+$273,629
Number of buys
5
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP H9060V101?
CUSIP H9060V101 identifies VECT - VECTIVBIO HOLDING - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of VECTIVBIO HOLDING - Stock (VECT) as of Q1 2022

As of 31 Mar 2022, VECTIVBIO HOLDING - Stock (VECT) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,339,231 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Novo Holdings A/S, CHI Advisors LLC, Bpifrance SA, CITADEL ADVISORS LLC, EVENTIDE ASSET MANAGEMENT, LLC, Cormorant Asset Management, LP, Tekla Capital Management LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, and UBS Group AG. This page lists 16 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.